1. Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents
- Author
-
Ernest Hamel, Ruoli Bai, Giampietro Viola, Alessandra Locatelli, Alberto Leoni, Andrea Brancale, Federica Maccarinelli, Mirella Rambaldi, Elena Mattiuzzo, Roberta Bortolozzi, Roberto Ronca, Rita Morigi, and Morigi, R., Locatelli, A., Leoni, A., Rambaldi, M., Bortolozzi, R., Mattiuzzo, E., Ronca, R., Maccarinelli, F., Hamel, E., Bai, R., Brancale, A., Viola, G.
- Subjects
Indoles ,Apoptosis ,Chemistry Techniques, Synthetic ,3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones ,Antiproliferative ,Antitumor ,Synthesis ,Antineoplastic Agents ,Caspase 3 ,Caspase 9 ,Cell Proliferation ,Down-Regulation ,Drug Screening Assays, Antitumor ,Enzyme Activation ,G2 Phase ,HeLa Cells ,Humans ,Mitochondria ,Structure-Activity Relationship ,Drug Screening Assays ,01 natural sciences ,HeLa ,Drug Discovery ,Pharmacology ,Drug Discovery3003 Pharmaceutical Science ,Organic Chemistry ,Cytotoxic T cell ,3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones, Antiproliferative, Antitumor, Apoptosis, Synthesis ,0303 health sciences ,biology ,Chemistry ,General Medicine ,3-(5-imidazo[2 ,03 medical and health sciences ,In vivo ,medicine ,1-b]thiazolylmethylene)-2-indolinones ,Structure–activity relationship ,030304 developmental biology ,010405 organic chemistry ,Cell growth ,Synthetic ,Cancer ,Chemistry Techniques ,medicine.disease ,biology.organism_classification ,In vitro ,0104 chemical sciences ,Cancer research - Abstract
A small library of 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones has been synthesized and screened according to protocols available at the National Cancer Institute (NCI). Some derivatives were potent antiproliferative agents, showing GI 50 values in the nanomolar range. Remarkably, when most active compounds against leukemia cells were tested in human peripheral blood lymphocytes from healthy donors, were 100–200 times less cytotoxic. Some compounds, selected by the Biological Evaluation Committee of NCI, were examined to determine tubulin assembly inhibition. Furthermore, flow cytometric studies performed on HeLa, HT-29, and A549 cells, showed that compounds 14 and 25 caused a block in the G2/M phase. Interestingly, these derivatives induced apoptosis through the mitochondrial death pathway, causing in parallel significant activation of both caspase-3 and -9, PARP cleavage and down-regulation of the anti-apoptotic proteins Bcl-2 and Mcl-1. Finally, compound 25 was also tested in vivo in the murine BL6-B16 melanoma and E0771 breast cancer cells, causing in both cases a significant reduction in tumor volume.
- Published
- 2019